Net Cash Provided by (Used in) Operating Activities |
-140K |
USD |
-23.2% |
Mar 31, 2023 |
Q1 2023 |
Net Cash Provided by (Used in) Financing Activities |
1.27K |
USD |
|
Mar 31, 2023 |
Q1 2023 |
Net Cash Provided by (Used in) Investing Activities |
-112K |
USD |
|
Mar 31, 2023 |
Q1 2023 |
Common Stock, Shares, Issued |
30M |
shares |
|
Mar 31, 2023 |
Q1 2023 |
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents |
498K |
USD |
-56.8% |
Jun 30, 2023 |
Q2 2023 |
Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent |
0.21 |
pure |
0% |
Jun 30, 2023 |
Q2 2023 |
Deferred Tax Assets, Gross |
335K |
USD |
+72% |
Dec 31, 2022 |
Q4 2022 |
Deferred Tax Assets, Operating Loss Carryforwards |
992 |
USD |
|
Dec 31, 2022 |
Q4 2022 |
Deferred Federal Income Tax Expense (Benefit) |
217K |
USD |
+84.2% |
Dec 31, 2022 |
Q4 2022 |
Preferred Stock, Shares Authorized |
1M |
shares |
0% |
Jun 30, 2023 |
Q2 2023 |
Current Federal Tax Expense (Benefit) |
901K |
USD |
+56192% |
Dec 31, 2022 |
Q4 2022 |
Deferred State and Local Income Tax Expense (Benefit) |
76.8K |
USD |
|
Dec 31, 2022 |
Q4 2022 |
Preferred Stock, Par or Stated Value Per Share |
0 |
USD/shares |
0% |
Jun 30, 2023 |
Q2 2023 |